100% Secure Payments
Tender Details
- Country: USA
- Summary: Exploratory/Developmental Bioengineering Research Grants (Ebrg) (R21 Clinical Trial Optional)
- UST Ref No: 62070176
- Deadline: 07 Jan 2025
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: -
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PAR-22-091
- Purchaser's Detail :
- Description :
- Tender are invited for Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
CFDA Number : 93.393 -- Cancer Cause and Prevention Research93.394 -- Cancer Detection and Diagnosis Research93.395 -- Cancer Treatment Research93.396 -- Cancer Biology Research93.399 -- Cancer Control
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Jan 07, 2025
Posted Date : Jan 11, 2022
Description: The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility. - Documents :
Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER WebmasterOERWebmaster03@od.nih.gov
Email :OERWebmaster03@od.nih.gov
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
